Bilastuff AB 10 Tablet contains Bilastine 10mg + Acebrophylline 200mg, a dual-action therapy designed for effective management of respiratory conditions such as allergic rhinitis, bronchitis, and mild asthma. Bilastine provides fast-acting antihistamine relief, while Acebrophylline works to dilate airways, reduce mucus, and improve breathing comfort.
This combination is increasingly prescribed due to its clinical effectiveness and patient tolerability, providing reliable symptom relief and improving adherence to therapy. Patients experience enhanced respiratory comfort, reduced allergy symptoms, and better overall lung function.
For franchise partners, Bilastuff AB 10 Tablet is a high-demand product in the respiratory care segment, offering strong prescriber trust and repeat prescription potential. Its dual-action formula ensures consistent market demand, making it a profitable addition to specialty portfolios.
With the growing prevalence of allergy and respiratory disorders, Bilastuff AB 10 Tablet provides sustainable sales opportunities, helping partners expand their footprint in the respiratory care segment while strengthening business growth.